Articles

The US Food and Drug Administration (FDA) has expanded the indication for the Gardasil-9 (Merck) vaccine to include prevention of oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58. This new indication is approved under the FDA’s accelerated approval program and is based on the

Among people who have the most common type of lung cancer, up to 40% develop metastatic brain tumors, with an average survival time of less than six months. But why non-small-cell lung cancer so often spreads to the brain has been poorly understood. Now scientists at Wake Forest School of Medicine have found that nicotine,

The FDA approved apalutamide (Erleada, Janssen Biotech, Inc.) to treat patients with nonmetastatic castration-resistant prostate cancer. Androgen-deprivation therapy (ADT) is an effective and integral part of care for patients with nonmetastatic prostate cancer. However, resistance to ADT is inevitable and develops in almost all cases of prostate cancer. Preventing metastasis to bone and other sites

An investigational new drug for androgen deprivation therapy (ADT) in prostate cancer has shown superiority over the standard therapy leuprolide, and could change practice once it is available, experts have suggested. The new drug is relugolix (Relumina, Myovant Sciences), an oral gonadotropin-releasing hormone (GnRH) antagonist already approved in Japan for use in the treatment of uterine fibroids. Relugolix has the

World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus highlighted the importance of stronger health systems and the investment in health for all people. “The pandemic has shown again, and in the strongest way possible, that investing in health is not just the right thing to do, it’s the smart thing to do,” he said at

MTX110, the new formulation of panobinostat, has shown promise in laboratory models of medulloblastoma. It is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma. According to the American Cancer Society, about 500 children are diagnosed with medulloblastoma every year.

Highlights : World Hypertension Day is observed on 17th May every year Aims to create awareness about hypertension and its risks among the general public Extra care is needed for people with hypertension to protect them during this COVID-19 pandemic Theme for the year 2020 is ‘Know Your Numbers’ World Hypertension Day is celebrated globally

Helpful ways to strengthen your immune system and fight off disease How can you improve your immune system? On the whole, your immune system does a remarkable job of defending you against disease-causing microorganisms. But sometimes it fails: A germ invades successfully and makes you sick. Is it possible to intervene in this process and

Highlights : World Thalassemia Day is observed on 8th May every year On this day, awareness of thalassemia is spread across the world Encouraging thalassemic patients can help them fight the disease bravely World Thalassemia Day is observed every year on 8th May. The objective of this day is to create awareness about thalassemia among

World Hand Hygiene Day is observed globally every year on 5th May by the World Health Organization (WHO). This day aims at creating awareness on hand hygiene and to provide effective hand hygiene practices to achieve better health and well-being. Who’s the Father of Hand Hygiene? Hand hygiene is one of the most effective methods to

International Workers’ Day, also known as Labour Day in some countries and often referred to as May Day, is a celebration of labourers and the working classes that is promoted by the international labour movement and occurs every year on May Day (1 May). While it may belong to a tradition of spring festivals, the date was chosen in 1889 for political reasons by the Marxist International Socialist

Elevated ferritin concentrations are linked to increased production of special signaling molecules, which can lead to complications and death, reports a new study. The findings of the study are published in the journal Autoimmunity Reviews. Yehuda Shoenfeld is the world’s leading expert in the research, treatment, and prevention of autoimmune diseases. Professor Shoenfeld noted that the